Drug Facts
Active Ingredient:
Purpose:
(in each extended-release
bi-layer tablet)
Guaifenesin 600 mg Expectorant
Uses:
Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Warnings:
Do not use
for children under 12 years of age
Ask a doctor before use if you have
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
cough accompanied by too much phlegm (mucus)
Stop use and ask a doctor if
cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
If pregnant or breast-feeding,
ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions:
do not crush, chew, or break tablet
take with a full glass of water
this product can be administered without regard for the timing of meals
adults and children 12 years of age and over: one or two tablets every 12 hours. Do not exceed 4 tablets in 24 hours.
children under 12 years of age: do not use
Other Information:
Inactive Ingredients:
carbomer 934P, NF; FD&C blue #1 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
How Supplied:
Bottles of 20 tablets (NDC 63824-008-20), 40 tablets (NDC 63824-008-40), sample bottles of 2 tablets (NDC 63824-008-82), 100 tablets (NDC 63824-008-10) and 500 tablets (NDC 63824-008-50). A round bi-layer tablet debossed with "A" on the light blue, marbled layer and "600" on the white layer. Each tablet provides 600 mg guaifenesin.
US Patent No. 6,372,252 B1
PRODUCT PHOTO(S):
NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual
or relative
size.
The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug's identity should be verified by chemical analysis.
Copyright© 2006 Thomson PDR